Article Details

TL1A Inhibitor Market to Grow by 2034 as Merck, Roche, Teva, and Sanofi Advance Clinical ...

Retrieved on: 2025-09-25 22:05:08

Tags for this article:

Click the tags to see associated articles and topics

TL1A Inhibitor Market to Grow by 2034 as Merck, Roche, Teva, and Sanofi Advance Clinical .... View article details on hiswai:

Excerpt

Industry leaders such as Merck, Roche, Teva Pharmaceuticals, and Sanofi are actively driving progress in this field, with a focus on multi-indication ...

Article found on: www.geneonline.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo